CC-90011 besylate
98%
- Product Code: 108074
CAS:
2097523-60-7
| Molecular Weight: | 595.62 g./mol | Molecular Formula: | C₂₉H₂₇F₂N₅O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Used in the treatment of certain cancers, particularly in clinical trials targeting acute myeloid leukemia (AML). It functions as a selective inhibitor of lysine-specific demethylase 1 (LSD1), which plays a role in gene regulation and cancer progression. By inhibiting LSD1, it helps to reactivate tumor suppressor genes and induce differentiation in cancer cells. This makes it a promising therapeutic agent for patients with relapsed or refractory AML. Ongoing research is exploring its efficacy in combination with other treatments to enhance anti-cancer effects.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | €926.01 |
+
-
|
CC-90011 besylate
Used in the treatment of certain cancers, particularly in clinical trials targeting acute myeloid leukemia (AML). It functions as a selective inhibitor of lysine-specific demethylase 1 (LSD1), which plays a role in gene regulation and cancer progression. By inhibiting LSD1, it helps to reactivate tumor suppressor genes and induce differentiation in cancer cells. This makes it a promising therapeutic agent for patients with relapsed or refractory AML. Ongoing research is exploring its efficacy in combination with other treatments to enhance anti-cancer effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :